Review



metacoretm analytical suite version 5.2 build 17389  (GeneGo Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GeneGo Inc metacoretm analytical suite version 5.2 build 17389
    Metacoretm Analytical Suite Version 5.2 Build 17389, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/metacoretm+analytical+suite+version+5%2E2+build+17389/metacoretm+analytical+suite+version+5+2+build+17389/pmc03540132-109-8-15
    Average 90 stars, based on 1 article reviews
    metacoretm analytical suite version 5.2 build 17389 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Generated:

    Article Title: Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest
    Article Snippet: Direct interaction network of genes was generated using MetacoreTM analytical suite version 5.2 build 17389 (GeneGo, Inc.) 30 , 31 Quantitative polymerase chain reaction (qPCR) was carried out to validate p21 gene expression.

    Article Title: Inflammation-Induced Endothelial-to-Mesenchymal Transition
    Article Snippet: Gene regulatory networks were generated using MetaCoreTM analytical suite version 5.2 build 17389 (GeneGo, St Joseph, MI).

    Real-time Polymerase Chain Reaction:

    Article Title: Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest
    Article Snippet: Direct interaction network of genes was generated using MetacoreTM analytical suite version 5.2 build 17389 (GeneGo, Inc.) 30 , 31 Quantitative polymerase chain reaction (qPCR) was carried out to validate p21 gene expression.

    Article Title: Inflammation-Induced Endothelial-to-Mesenchymal Transition
    Article Snippet: Gene regulatory networks were generated using MetaCoreTM analytical suite version 5.2 build 17389 (GeneGo, St Joseph, MI).

    Gene Expression:

    Article Title: Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest
    Article Snippet: Direct interaction network of genes was generated using MetacoreTM analytical suite version 5.2 build 17389 (GeneGo, Inc.) 30 , 31 Quantitative polymerase chain reaction (qPCR) was carried out to validate p21 gene expression.

    Article Title: Inflammation-Induced Endothelial-to-Mesenchymal Transition
    Article Snippet: Gene regulatory networks were generated using MetaCoreTM analytical suite version 5.2 build 17389 (GeneGo, St Joseph, MI).



    Similar Products

    90
    GeneGo Inc metacoretm analytical suite version 5.2 build 17389
    Metacoretm Analytical Suite Version 5.2 Build 17389, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/metacoretm+analytical+suite+version+5%2E2+build+17389/metacoretm+analytical+suite+version+5+2+build+17389/pmc03540132-109-8-15
    Average 90 stars, based on 1 article reviews
    metacoretm analytical suite version 5.2 build 17389 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results